Challenges of ophthalmic care in the developingworld

Alfred Sommer, Hugh R. Taylor, Thulasiraj D. Ravilla, Sheila West, Thomas M. Lietman, Jeremy D. Keenan, Michael Chiang, Alan L. Robin, Richard P. Mills

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Global blindness exacts an enormous financial and social cost on developing countries. Reducing the prevalence of blindness globally requires a set of strategies that are different from those typically used in developed countries. Thiswas the subject of the 2013 Knapp symposium at the American Ophthalmological Society Annual Meeting, and this article summarizes the presentations of epidemiologists, health care planners, and ophthalmologists. It explores a range of successful strategies from the multinational Vision 2020 Initiative to disease-specific schemes in cataract, trachoma control, infectious corneal ulceration, cytomegalovirus retinitis, and retinopathy of prematurity. In each example, the importance of an attitudinal change set toward public health becomes clear. There is reason for optimism in the struggle against global blindness in large measure because of innovative programs such as those described here.

Original languageEnglish (US)
Pages (from-to)640-644
Number of pages5
JournalJAMA Ophthalmology
Volume132
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Blindness
Cytomegalovirus Retinitis
Trachoma
Retinopathy of Prematurity
Developed Countries
Cataract
Developing Countries
Public Health
Delivery of Health Care
Costs and Cost Analysis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Sommer, A., Taylor, H. R., Ravilla, T. D., West, S., Lietman, T. M., Keenan, J. D., ... Mills, R. P. (2014). Challenges of ophthalmic care in the developingworld. JAMA Ophthalmology, 132(5), 640-644. https://doi.org/10.1001/jamaophthalmol.2014.84

Challenges of ophthalmic care in the developingworld. / Sommer, Alfred; Taylor, Hugh R.; Ravilla, Thulasiraj D.; West, Sheila; Lietman, Thomas M.; Keenan, Jeremy D.; Chiang, Michael; Robin, Alan L.; Mills, Richard P.

In: JAMA Ophthalmology, Vol. 132, No. 5, 2014, p. 640-644.

Research output: Contribution to journalArticle

Sommer, A, Taylor, HR, Ravilla, TD, West, S, Lietman, TM, Keenan, JD, Chiang, M, Robin, AL & Mills, RP 2014, 'Challenges of ophthalmic care in the developingworld', JAMA Ophthalmology, vol. 132, no. 5, pp. 640-644. https://doi.org/10.1001/jamaophthalmol.2014.84
Sommer A, Taylor HR, Ravilla TD, West S, Lietman TM, Keenan JD et al. Challenges of ophthalmic care in the developingworld. JAMA Ophthalmology. 2014;132(5):640-644. https://doi.org/10.1001/jamaophthalmol.2014.84
Sommer, Alfred ; Taylor, Hugh R. ; Ravilla, Thulasiraj D. ; West, Sheila ; Lietman, Thomas M. ; Keenan, Jeremy D. ; Chiang, Michael ; Robin, Alan L. ; Mills, Richard P. / Challenges of ophthalmic care in the developingworld. In: JAMA Ophthalmology. 2014 ; Vol. 132, No. 5. pp. 640-644.
@article{a7b983a3156a41728a52a95815b43358,
title = "Challenges of ophthalmic care in the developingworld",
abstract = "Global blindness exacts an enormous financial and social cost on developing countries. Reducing the prevalence of blindness globally requires a set of strategies that are different from those typically used in developed countries. Thiswas the subject of the 2013 Knapp symposium at the American Ophthalmological Society Annual Meeting, and this article summarizes the presentations of epidemiologists, health care planners, and ophthalmologists. It explores a range of successful strategies from the multinational Vision 2020 Initiative to disease-specific schemes in cataract, trachoma control, infectious corneal ulceration, cytomegalovirus retinitis, and retinopathy of prematurity. In each example, the importance of an attitudinal change set toward public health becomes clear. There is reason for optimism in the struggle against global blindness in large measure because of innovative programs such as those described here.",
author = "Alfred Sommer and Taylor, {Hugh R.} and Ravilla, {Thulasiraj D.} and Sheila West and Lietman, {Thomas M.} and Keenan, {Jeremy D.} and Michael Chiang and Robin, {Alan L.} and Mills, {Richard P.}",
year = "2014",
doi = "10.1001/jamaophthalmol.2014.84",
language = "English (US)",
volume = "132",
pages = "640--644",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Challenges of ophthalmic care in the developingworld

AU - Sommer, Alfred

AU - Taylor, Hugh R.

AU - Ravilla, Thulasiraj D.

AU - West, Sheila

AU - Lietman, Thomas M.

AU - Keenan, Jeremy D.

AU - Chiang, Michael

AU - Robin, Alan L.

AU - Mills, Richard P.

PY - 2014

Y1 - 2014

N2 - Global blindness exacts an enormous financial and social cost on developing countries. Reducing the prevalence of blindness globally requires a set of strategies that are different from those typically used in developed countries. Thiswas the subject of the 2013 Knapp symposium at the American Ophthalmological Society Annual Meeting, and this article summarizes the presentations of epidemiologists, health care planners, and ophthalmologists. It explores a range of successful strategies from the multinational Vision 2020 Initiative to disease-specific schemes in cataract, trachoma control, infectious corneal ulceration, cytomegalovirus retinitis, and retinopathy of prematurity. In each example, the importance of an attitudinal change set toward public health becomes clear. There is reason for optimism in the struggle against global blindness in large measure because of innovative programs such as those described here.

AB - Global blindness exacts an enormous financial and social cost on developing countries. Reducing the prevalence of blindness globally requires a set of strategies that are different from those typically used in developed countries. Thiswas the subject of the 2013 Knapp symposium at the American Ophthalmological Society Annual Meeting, and this article summarizes the presentations of epidemiologists, health care planners, and ophthalmologists. It explores a range of successful strategies from the multinational Vision 2020 Initiative to disease-specific schemes in cataract, trachoma control, infectious corneal ulceration, cytomegalovirus retinitis, and retinopathy of prematurity. In each example, the importance of an attitudinal change set toward public health becomes clear. There is reason for optimism in the struggle against global blindness in large measure because of innovative programs such as those described here.

UR - http://www.scopus.com/inward/record.url?scp=84900406285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900406285&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2014.84

DO - 10.1001/jamaophthalmol.2014.84

M3 - Article

VL - 132

SP - 640

EP - 644

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 5

ER -